Robotic-assisted intervention enables precise measurement of anatomy and device positioning - with the added benefit of radiation protection for the clinician - and reduces radiation exposure for staff and patients.
During a CorPath robotic-assisted intervention, clinicians can sit in a radiation-shielded workstation and use a set of joysticks and touchscreen controls, that translate their movements into precise device control.
A recent PRECISE trial* showed:
- 97.6% clinical overall success rate with no reports of device-related complications.
- The average radiation exposure to the Interventional Cardiologist decreased by 95.2%, compared to levels reported during standard interventions.
The CorPath GRX is the only CE marked and FDA cleared Robotic System for Coronary and Peripheral Vascular Interventions.